Subscribe
shutterstock_221247631_f11photo
f11photo / Shutterstock.com
18 February 2021BiotechnologyMuireann Bolger

Texas uni loses bid to shield cancer vaccine patents from IPRs

The University of Texas (UT) has failed to persuade the US Court of Appeals for the Federal Circuit to review a ruling that prevented it from using sovereign immunity to protect its cancer vaccine patents from inter partes reviews (IPRs).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Texas Uni’s sovereign immunity fail went as expected
4 March 2021   The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.
Americas
Texas uni wants Supreme Court to settle state sovereignty rules
12 March 2020   The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.
Americas
Texas universities sue J&J subsidiary over biodegradable fibres
17 November 2017   A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.


Editor's picks

LSPN: In-house ‘chess game’ is the same, but the rules have changed
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

Editor's picks

Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025

More on this story

Americas
Texas Uni’s sovereign immunity fail went as expected
4 March 2021   The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.
Americas
Texas uni wants Supreme Court to settle state sovereignty rules
12 March 2020   The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.
Americas
Texas universities sue J&J subsidiary over biodegradable fibres
17 November 2017   A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

More on this story

Americas
Texas Uni’s sovereign immunity fail went as expected
4 March 2021   The result of the sovereign immunity bid mirrored previous cases but we did learn something about the opinions of Justices on the issue, says Gary Frischling of Milbank.
Americas
Texas uni wants Supreme Court to settle state sovereignty rules
12 March 2020   The University of Texas has asked the Supreme Court to rule that state-owned institutions should escape the normal rules determining the appropriate venue for filing patent lawsuits.
Americas
Texas universities sue J&J subsidiary over biodegradable fibres
17 November 2017   A group of 14 educational institutions in Texas and biotech company TissueGen have sued a subsidiary of Johnson & Johnson for infringing two patents covering biodegradable fibres.

More features

Sanofi unit loses genetic disorder patent at EPO after trio of challenges
INTA confirms London as host city for Annual Meeting 2026
INTA unveils key principles on AI and IP rights at Annual Meeting
Illumina takes aim at rival in gene sequencing spat
Novartis tops Big Pharma in global trademark portfolios
PierFerd hires partner with medtech expertise
NanoString to pay 10x Genomics $68m in global settlement
Federal Circuit revives CRISPR feud citing PTAB errors